Circulation: Cardiovascular Interventions

DECEMBER 28, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. We examined patient, hospital, and geographic characteristics associated with the intensity of vascular care received the year before amputation. 0.98];P=0.019), and those who received care at a safety-net hospital (odds ratio, 0.87 [95% CI, 0.78–0.97];P=0.012)

Vascular Care 61

Vascular Care Ischemia Medicare Hospital 61

Circulation: Cardiovascular Interventions

APRIL 7, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:The extent of cardiac damage has been shown to be associated with increased mortality, repeat hospitalization, and decreased quality of life after aortic valve replacement (AVR).

Aortic valve 40

Aortic valve Aortic Heart Failure Quality of Life 40

Circulation: Cardiovascular Interventions

JANUARY 24, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Intravascular imaging (IVI) is widely recognized to improve outcomes after percutaneous coronary intervention (PCI). As a pass/fail performance measure, reliability was high (>0.96) at hospital and physician levels. in 2010 to 43.1%

Hospital 45

Hospital Ultrasound Cardiovascular Interventions Outcomes 45

DAIC

FEBRUARY 14, 2025

10, 2025 A generous gift of $5 million from Lorraine and Bill Dodero will establish the Lorraine and Bill Dodero Limb Preservation Center at University Hospitals Harrington Heart & Vascular Institute in Cleveland, Ohio. Lorraine and Bill Dodero tim.hodson Fri, 02/14/2025 - 15:33 Feb.

Peripheral Arterial Disease 52

Peripheral Arterial Disease Cancer Innovation Best Practices 52

DAIC

MARCH 15, 2024

Tang is currently serving as a professor in the Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai , the surgical director of the Structural Heart Program at the Mount Sinai Health System , and the director of Structural Heart Education at the Mount Sinai Fuster Heart Hospital in New York.

TAVR 105

TAVR Academic Education Cardiovascular Surgery 105

Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:The American College of Cardiology Reduce the Risk: PCI Bleed Campaign was a hospital-based quality improvement campaign designed to reduce post-percutaneous coronary intervention (PCI) bleeding events.

Myocardial Infarction 45

Myocardial Infarction Hospital Cardiovascular Interventions Outcomes 45

Open Heart

MARCH 28, 2023

Background COVID-19 pandemic led to a reduction in hospital admissions and intervention for other diseases in many countries. We aimed to assess the effect of COVID-19 pandemic on cardiovascular disease (CVD) hospitalisations, management and mortality in Switzerland.

COVID-19 52

COVID-19 Cardiovascular Disease Angioplasty Hospital 52

Circulation: Cardiovascular Interventions

MARCH 26, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. The primary outcome was a composite of death from any cause, stroke/transient ischemic attack, and procedure-related or valve-related hospitalization at 30 days and at 1 year. versus 4.3%; hazard ratio, 2.93 [95% CI, 1.455.94]). andP=0.001, respectively).

Aortic valve 40

Aortic valve Aortic Stenosis TAVR 40

Open Heart

JULY 17, 2023

Objective Deferral of non-emergency cardiac procedures is associated with increased early emergency cardiovascular hospitalisation. This study aimed to identify predictors of worse clinical outcome after deferral of non-emergency cardiovascular interventions. Arterial hypertension (HR 2.27; 95% CI 1.00

COVID-19 52

COVID-19 Outcomes Cardiovascular Interventions Risk Factors 52

Circulation: Cardiovascular Interventions

JANUARY 18, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. with functional MR) who underwent an isolated, first-time intervention. with functional MR) who underwent an isolated, first-time intervention. METHODS:We retrospectively analyzed 968 individuals (median age, 79 [interquartile range, 70–86] years; 60.0%

Bicuspid/Mitral 40

Bicuspid/Mitral Outcomes Heart Failure Echocardiogram 40

Circulation: Cardiovascular Interventions

FEBRUARY 20, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Patients with ST-segment–elevation myocardial infarction but no coronary microvascular injury are at low risk of early cardiovascular complications (ECC).

Myocardial Infarction 40

Myocardial Infarction STEMI Cardiogenic Shock Cardiac Arrest 40

Circulation: Cardiovascular Interventions

FEBRUARY 13, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Improved radiation safety practices are needed across hospitals performing percutaneous coronary intervention (PCI).

Cardiovascular Interventions 40

Cardiovascular Interventions Education Hospital Circulation 40

Circulation: Cardiovascular Interventions

DECEMBER 4, 2024

Circulation: Cardiovascular Interventions, Ahead of Print.

Cardiovascular Interventions 40

Cardiovascular Interventions Technology Circulation Hospital 40

Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. INTRODUCTION:Percutaneous coronary intervention for complex coronary disease is associated with a high risk of cardiogenic shock. This can cause harm and limit the quality of revascularization achieved, especially when left ventricular function is impaired at the outset.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Coronary Artery Disease Quality of Life 40

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. Poverall=NS) were nonsignificant, and the incidence of overall in-hospital complications was comparable among groups. BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. 2.44];P=0.035).

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic Tricuspid 40

Circulation: Cardiovascular Interventions

DECEMBER 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Varying rates of nonsustained ventricular tachycardia (NSVT) have been reported early after transcatheter pulmonary valve replacement (TPVR) with the Harmony valve, but data regarding rhythm outcomes beyond hospital discharge are limited.

Pulmonary 40

Pulmonary Arrhythmia Cardiovascular Interventions Tachycardia 40

Circulation: Cardiovascular Interventions

JANUARY 31, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:In patients with ST-segment–elevation myocardial infarction complicated by cardiogenic shock, primary percutaneous coronary intervention (pPCI) is the preferred revascularization option. pharmacoinvasive and 46.2% pharmacoinvasive and 46.2%

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Cardiac Arrest Cardiovascular Interventions 40

Circulation: Cardiovascular Interventions

JANUARY 20, 2025

Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014499, January 1, 2025. days;P=0.01) and hospital length of stay (5.0 METHODS:This retrospective cohort study analyzed data from 2 academic centers involving patients with intermediate-risk PE from January 2020 to January 2024. days;P=0.046).

Embolism 40

Embolism Pulmonary Outcomes Cardiac Arrest 40

Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. 1.22]), in-hospital mortality (odds ratio, 0.64 [95% CI, 0.17–2.19]), Background:The role of advanced therapies (systemic thrombolysis, catheter-based treatment, and surgical thrombectomy) for the management of right heart thrombus is poorly defined.

Outcomes 40

Outcomes Thrombolysis Embolism Pulmonary 40

Circulation

NOVEMBER 11, 2024

Background:The CHIP score, developed from the BCIS (British Cardiovascular Intervention Society) database, predicts adverse in-hospital MACCE (major adverse cardiovascular and cerebrovascular events). Circulation, Volume 150, Issue Suppl_1 , Page A4142612-A4142612, November 12, 2024.

Myocardial Infarction 40

Myocardial Infarction Cardiovascular Interventions Stroke Strokes 40

DAIC

OCTOBER 16, 2024

16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial results in Circulation: Cardiovascular Interventions , a journal of The American Heart Association. tim.hodson Wed, 10/16/2024 - 09:00 Oct. Led by Dr. Pieter C. Principal Investigator, Dr. Pieter C.

Stents 52

Stents Stent Thrombosis Coronary Artery Disease 52

All About Cardiovascular System and Disorders

MARCH 20, 2024

But, RASER did not increase the likelihood of in-hospital Major Adverse Cardiac and Cerebral Events and major bleeding or death. When you combine two procedures, there is of course there is an increased rate of induction of shock, slow flow and arterial complications.

Angioplasty 52

Angioplasty Plaque Stents Stent 52

Dr. Smith's ECG Blog

DECEMBER 7, 2023

Circulation: Cardiovascular Interventions , 7(5), 645–655. On hospital day 3, the patient had recurrence of symptoms and the following EKG was obtained. Dr. Frick's Interpretation of ECG #5 : CP did not recur during the remainder of the hospital stay. Starovoytov, A., Robinson, S., Vuurmans, T., Humphries, K., &

SCAD 124

SCAD Ischemia Coronary Artery Disease Cardiomyopathy 124

DAIC

MARCH 15, 2024

Tang is currently serving as a professor in the Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai , the surgical director of the Structural Heart Program at the Mount Sinai Health System, and the director of Structural Heart Education at the Mount Sinai Fuster Heart Hospital in New York.

TAVR 52

TAVR Academic Education Cardiovascular Surgery 52

The Beat Blog

MAY 2, 2023

I’ve worked with hospitals, provider groups and payers – trying to help drive the right type of access, care, and value across the healthcare continuum. 1 That problem is exacerbated by the lack of access to acute care: Since 2011, two-thirds of the hospital closures in the U.S. have been in rural areas. For the Risk Bearing Entity e.g

Atrial Fibrillation 52

Atrial Fibrillation Cardiovascular Disease Technology Hospital 52

DAIC

DECEMBER 26, 2023

Professor of Medicine at the Yale School of Medicine and Director of the Y ale New Haven Hospital Center for Outcomes Research and Evaluation. Krumholz is the Harold H.

Innovation 52

Innovation Research Cardiovascular Imaging Electrophysiology 52

Dr. Smith's ECG Blog

JUNE 18, 2013

He was admitted to the hospital for a "rule out." This is such a subtle ECG that I was worried that it had gone unnoticed, and, in fact, it did go unnoticed: His pain continued and his ECG was read as normal. His first troponin was normal. His second troponin I returned at t = 5 hours and was + at 3.8 Marti D et al.

STEMI 52

STEMI Chest Pain Myocardial Infarction Webinar 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Dr. Smith's ECG Blog

JANUARY 24, 2025

Why is a patient allowed to present in the hyperacute phase of LAD OMI and complete his infarct in the hospital under physician care? J Cardiovascular Interventions.--20/53 Discussion: Why do we let this happen in the era of modern cardiac catheterization and PCI? We could hardly ask for a more obvious clinical history.

Chest Pain 124

Chest Pain STEMI Risk Factors Coronary Artery Disease 124

Cardiometabolic Health Congress

NOVEMBER 22, 2024

Heart Failure Management : The FINEARTS-HF trial focused on the efficacy of finerenone, an aldosterone antagonist, in reducing heart failure hospitalizations and cardiovascular mortality among patients with preserved ejection fraction (HFpEF).

Blood Pressure 59

Blood Pressure Obesity Preserved Ejection Fraction Coronary Artery Disease 59

Dr. Smith's ECG Blog

MARCH 17, 2025

Summary of RIDDLE-NSTEMI: RIDDLE-NSTEMI, JACC: Cardiovascular Interventions 2016 Limitations of conventional angiography: This patient was very lucky that the interventional cardiologist who responded to the cath lab activation is evidence based and thorough. This will not make it into any morbidity & mortality conferences.

STEMI 81

STEMI Chest Pain Myocardial Infarction Document 81